Hepatitis C virus infection and kidney transplantation
J.M. Morales(Hospital Universitario 12 De Octubre), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Josep M. Campistol(Universitat de Barcelona)
Cited by 47
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566
Donation after circulatory death today: an updated overview of the European landscape
|Transplant International|2019|317
COVID-19 pandemic and worldwide organ transplantation: a population-based study
|The Lancet Public Health|2021|312